Breakthrough technologies have become available to patients with cystic fibrosis

Abstract

In Russia, approximately 150–200 people are born every day with cystic fibrosis1, a severe, life-threatening disease that causes damage to almost every human organ. But the field of medicine is constantly evolving, which as a result allows patients to raise their quality of life and life expectancy. The advent of targeted therapy presented an opportunity for the greatest advances, which have made a significant contribution to improving clinical outcomes. Its role and the emergence of new, effective, safe, and more affordable drugs for the treatment of this group of patients were discussed by the leading Russian doctors who participated in the symposium “Targeted Therapy for Cystic Fibrosis”, which was held as part of the XXXV National Congress on Respiratory Diseases.